Abiopharma

🔍 Dormo Jeffrey Harrison (Executive)

Company: Solstice Advanced Materials Inc. (SOLS)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,719 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,807.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,267 shares of Common Stock at $81.58 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,540.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,719 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,437.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Holds 19,744 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 19,744.00 | Footnotes: F1, F4, F4
• Holds 3,173 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 3,173.00 | Footnotes: F1, F5, F5
• Holds 1,697 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 1,697.00 | Footnotes: F1, F6, F6
• Holds 2,315 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 2,315.00 | Footnotes: F1, F7, F7
• Holds 3,406 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 3,406.00 | Footnotes: F1, F8, F8
• Holds 3,086 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 3,086.00 | Footnotes: F1, F9, F9
• Holds 10,194 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 10,194.00 | Footnotes: F1, F10, F10
• Holds 7,122 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: H | shares_owned_after: 7,122.00 | Footnotes: F1, F11, F11
• Holds 2,794 shares of Stock Option (Right to buy) at $44.95 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2032-02-10 | shares_owned_after: 2,794.00 | Footnotes: F12
• Holds 4,812 shares of Stock Option (Right to buy) at $46.03 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2033-02-22 | shares_owned_after: 4,812.00 | Footnotes: F13
• Holds 12,858 shares of Stock Option (Right to buy) at $46.79 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2034-02-28 | shares_owned_after: 12,858.00 | Footnotes: F14
• Holds 14,825 shares of Stock Option (Right to buy) at $50.59 per share (Derivative)
  Date: 2026-05-01 | Code: H | Expires: 2035-03-02 | shares_owned_after: 14,825.00 | Footnotes: F15

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock.
• F2: Represents shares withheld for taxes upon vesting of RSUs.
• F3: The RSUs vest in three equal installments on each of May 1, 2026, May 1, 2027 and May 1, 2028, subject to continued employment.
• F4: The RSUs will vest in equal installments on each of October 30, 2028 and October 30, 2029, subject to continued employment.
• F5: The RSUs will vest on July 30, 2026, subject to continued employment.
• F6: The RSUs will vest on July 29, 2027, subject to continued employment.
• F7: The RSUs will vest on July 28, 2026, subject to continued employment.
• F8: The RSUs will vest on March 1, 2027, subject to continued employment.
• F9: The RSUs will vest on March 3, 2028, subject to continued employment.
• F10: The RSUs will vest in equal installments on each of March 17, 2027 and March 17, 2028, subject to continued employment.
• F11: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment.
• F12: Options are fully vested and exercisable.
• F13: Options vest and become exercisable in equal installments on each of February 23, 2026 and February 23, 2027.
• F14: Options vest and become exercisable in three equal installments on each of March 1, 2026, March 1, 2027 and March 1, 2028.
• F15: Options vest and become exercisable in four equal installments on each of March 3, 2026, March 3, 2027, March 3, 2028 and March 3, 2029.